Cisen Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603367.SS

Cisen Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) on January 14, 2025: 1.01

Cisen Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) is 1.01 on January 14, 2025, a -20.23% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Cisen Pharmaceutical Co., Ltd. 52-week high Price to Book Ratio (P/B) is 1.34 on May 09, 2024, which is 32.43% above the current Price to Book Ratio (P/B).
Cisen Pharmaceutical Co., Ltd. 52-week low Price to Book Ratio (P/B) is 0.91 on February 05, 2024, which is -9.71% below the current Price to Book Ratio (P/B).
Cisen Pharmaceutical Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 1.10.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 603367.SS

Cisen Pharmaceutical Co., Ltd.

CEO	Mr. Zhenxin Du
IPO Date	Sept. 29, 2017
Location	China
Headquarters	Tongji Sci-tech Industrial Park
Employees	3,402
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Jining, the People's Republic of China.

Key trends

Past 5 years